Emmessar Biotech

Market Cap: Micro Cap
Industry: Commodity Chemicals
ISIN: INE634B01016
NSEID:
BSEID: 524768
View on BSE

INR

27.48

0.81 (3.04%)

BSENSE

Feb 03

BSE+NSE Vol: 1.14 k

{
  "main_header": {
    "sid": 879996,
    "name": "Emmessar Biotech",
    "stock_name": "Emmessar Biotech",
    "full_name": "Emmessar Biotech & Nutrition Ltd",
    "name_url": "stocks-analysis/emmessar-biotech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "27.48",
    "chg": 0.81,
    "chgp": "3.04%",
    "dir": 1,
    "prev_price": "26.67",
    "mcapval": "14.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524768,
    "symbol": "",
    "ind_name": "Commodity Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE634B01016",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.14 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/emmessar-biotech-879996-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Emmessar Biotech & Nutrition Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-emmessar-biotech-nutrition-ltd-fallingrising-3792421",
        "imagepath": "",
        "date": "2026-01-15 00:50:31",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>Emmessar Biotech’s share price has been on a downward trajectory over the past week, registering a loss of 9.43%, which starkly contrasts with the Sensex’s modest decline of 1.86% during the same period. The stock’s underperformance extends over longer time frames as well, with a one-month decline of 6.21% compared to the Sensex’s 2.21% drop. Year-to-date, the stock has fallen 6.37%, while the benchmark index has only decreased by 2.16%. Most notably, over the past year, Emmessar Biotech has suffered a steep 34.57% loss, whereas the Sensex has gained 9.00%, highlighting the stock’s persistent struggles relative to the broader market.</p>\n<p><strong>Technical Indicators Signal Continued Weakness</strong></p>\n<p>Technical analysis fur..."
      },
      {
        "title": "How has been the historical performance of Emmessar Biotech?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-emmessar-biotech-3695470",
        "imagepath": "",
        "date": "2025-11-13 00:26:09",
        "description": "Answer:\nThe historical performance of Emmessar Biotech shows significant fluctuations in its financial metrics over the years.\n\nBreakdown:\nEmmessar Biotech's net sales have varied considerably, peaking at 6.99 Cr in Mar'21 before declining to 0.61 Cr in Mar'25. The total operating income followed a similar trend, with a high of 6.99 Cr in Mar'21 and a drop to 0.61 Cr in Mar'25. The company's total expenditure, excluding depreciation, has also seen fluctuations, reaching a high of 6.14 Cr in Mar'21 and decreasing to 1.56 Cr in Mar'25. Operating profit (PBDIT) has been negative in recent years, with a loss of 0.95 Cr in Mar'25, contrasting with a profit of 0.85 Cr in Mar'21. Profit after tax has decreased from 1.45 Cr in Mar'21 to 0.32 Cr in Mar'25. The company's total assets have increased from 5.19 Cr in Mar'20 to 9.22 Cr in Mar'25, while total liabilities have also risen from 5.19 Cr to 9.22 Cr in the same..."
      },
      {
        "title": "Why is Emmessar Biotech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-emmessar-biotech-fallingrising-3693601",
        "imagepath": "",
        "date": "2025-11-12 22:58:18",
        "description": "As of 12-Nov, Emmessar Biotech & Nutrition Ltd's stock price is currently at 31.05, reflecting a slight increase of 0.05, or 0.16%. The stock has been gaining for the last two days, with a total return of 3.53% during this period. However, it has underperformed its sector by 0.92% today. In terms of longer-term performance, the stock has experienced a decline of 1.43% over the past month and a significant drop of 32.94% year-to-date. Despite these challenges, there has been a notable increase in investor participation, with delivery volume rising by 405.63% compared to the 5-day average, indicating growing interest in the stock.\n\nIn the broader market context, the Sensex has outperformed Emmessar Biotech, returning 1.21% over the past week and 2.38% over the past month, while the stock has seen negative returns in both timeframes. Year-to-date, the Sensex has gained 8.10%, contrasting sharply with Emmessar'..."
      },
      {
        "title": "When is the next results date for Emmessar Biotech?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-emmessar-biotech-3681227",
        "imagepath": "",
        "date": "2025-11-07 23:20:08",
        "description": "Emmessar Biotech will declare its results on 12 November 2025...."
      }
    ],
    "total": 57,
    "sid": "879996",
    "stock_news_url": "https://www.marketsmojo.com/news/emmessar-biotech-nutrition-879996"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "13-Jan-2026",
      "details": "Please refer attachment",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "24-Dec-2025",
      "details": "Refer attachment",
      "source": "BSE"
    },
    {
      "caption": "Newspaper Add",
      "datetime": "13-Nov-2025",
      "details": "Please refer attachment",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Emmessar Biotech & Nutrition Ltd falling/rising?

2026-01-15 00:50:31

Recent Price Movement and Market Comparison

Emmessar Biotech’s share price has been on a downward trajectory over the past week, registering a loss of 9.43%, which starkly contrasts with the Sensex’s modest decline of 1.86% during the same period. The stock’s underperformance extends over longer time frames as well, with a one-month decline of 6.21% compared to the Sensex’s 2.21% drop. Year-to-date, the stock has fallen 6.37%, while the benchmark index has only decreased by 2.16%. Most notably, over the past year, Emmessar Biotech has suffered a steep 34.57% loss, whereas the Sensex has gained 9.00%, highlighting the stock’s persistent struggles relative to the broader market.

Technical Indicators Signal Continued Weakness

Technical analysis fur...

Read full news article

How has been the historical performance of Emmessar Biotech?

2025-11-13 00:26:09

Answer: The historical performance of Emmessar Biotech shows significant fluctuations in its financial metrics over the years. Breakdown: Emmessar Biotech's net sales have varied considerably, peaking at 6.99 Cr in Mar'21 before declining to 0.61 Cr in Mar'25. The total operating income followed a similar trend, with a high of 6.99 Cr in Mar'21 and a drop to 0.61 Cr in Mar'25. The company's total expenditure, excluding depreciation, has also seen fluctuations, reaching a high of 6.14 Cr in Mar'21 and decreasing to 1.56 Cr in Mar'25. Operating profit (PBDIT) has been negative in recent years, with a loss of 0.95 Cr in Mar'25, contrasting with a profit of 0.85 Cr in Mar'21. Profit after tax has decreased from 1.45 Cr in Mar'21 to 0.32 Cr in Mar'25. The company's total assets have increased from 5.19 Cr in Mar'20 to 9.22 Cr in Mar'25, while total liabilities have also risen from 5.19 Cr to 9.22 Cr in the same...

Read full news article

Why is Emmessar Biotech falling/rising?

2025-11-12 22:58:18

As of 12-Nov, Emmessar Biotech & Nutrition Ltd's stock price is currently at 31.05, reflecting a slight increase of 0.05, or 0.16%. The stock has been gaining for the last two days, with a total return of 3.53% during this period. However, it has underperformed its sector by 0.92% today. In terms of longer-term performance, the stock has experienced a decline of 1.43% over the past month and a significant drop of 32.94% year-to-date. Despite these challenges, there has been a notable increase in investor participation, with delivery volume rising by 405.63% compared to the 5-day average, indicating growing interest in the stock. In the broader market context, the Sensex has outperformed Emmessar Biotech, returning 1.21% over the past week and 2.38% over the past month, while the stock has seen negative returns in both timeframes. Year-to-date, the Sensex has gained 8.10%, contrasting sharply with Emmessar'...

Read full news article